LONDON, June 24, 2025 /PRNewswire/ -- Enfuse Group, a leading digital transformation consultancy and certified B Corp, is delighted to announce a strategic investment from Agathos Management LLP, a UK ...
CINCINNATI, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® on-body drug delivery system, announced ...
The MarketWatch News Department was not involved in the creation of this content. Enable Injections Announces Agreement with Sobi(R) to Develop and Distribute Aspaveli(R) in Combination with enFuse(R) ...
CINCINNATI, May 22, 2026 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® On-Body Delivery System (OBDS), today ...
LONDON, Nov. 19, 2024 /PRNewswire/ -- Enfuse Group are on a mission to prove that being a high performing consultancy doesn't have to mean compromising on social and environmental responsibility. As ...
Enfuse Solutions IPO allotment: The allotment for Enfuse Solutions IPO will be finalised on March 20. Investors who have applied for the issue can check their allotment status on the website of the ...
Enfuse Solutions IPO share allotment will be finalised today.(https://www.enfuse-solutions.com/) Enfuse Solutions IPO allotment date has been fixed for today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results